YEATS2-AS1 manifested significantly elevated expression levels in multiple cancer tissues, encompassing PRAD, OV (Ovarian Cancer), and UCEC (Uterine Corpus Endometrial Carcinoma), in comparison to normal tissues, as illustrated in Fig. 9A. This pervasive overexpression pattern implies a potential oncogenic role for YEATS2-AS1 across diverse cancer types. This evidence concerns the gene YEATS2 and cancer.